| Notice of Special Interest (NOSI)—CCRP Administrative Supplement for Collaborative Science To Synergize Chemical Medical Countermeasures Discovery and Early Development - NOT-AI-22-029 |
Supp
|
February 25, 2022 |
March 02, 2024 |
| Notice of Special Interest (NOSI)—Complement in Basic Immunology (CIBI)- NOT-AI-21-008 |
R01, R21
|
February 04, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Harnessing Big Data To Halt HIV- NOT-AI-21-054 |
R01
|
June 22, 2021 |
May 08, 2024 |
| Notice of Special Interest (NOSI)—Immune Responses to Arthropod Feeding on Vertebrate Hosts- NOT-AI-21-059 |
R01, R21
|
July 29, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Innovation Research (R43/R44 Clinical Trial Optional)- NOT-ES-22-010 |
R43/R44
|
June 03, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072 |
R21
|
October 20, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals To Inform Innovative Tuberculosis Vaccine Design- NOT-AI-20-071 |
R01, R21
|
September 10, 2020 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082 |
R01, R21
|
November 29, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—NIAID Priorities for Biomedical Knowledgebases and Repositories- NOT-AI-20-044 |
U24
|
June 08, 2020 |
May 09, 2023 |
| Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival- NOT-AI-22-023 |
R21, R01
|
February 23, 2022 |
May 08, 2026 |
| Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)- NOT-AI-21-074 |
Supp
|
September 24, 2021 |
September 24, 2024 |
| Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-19-001 |
Multiple |
March 13, 2019 |
May 08, 2023 |
| Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-031 |
Supp
|
December 02, 2021 |
February 01, 2023 |
| Notice of Special Interest (NOSI)—Research Supplements To Promote Re-Entry and Re-Integration into Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)- NOT-OD-21-134 |
Supp
|
July 23, 2021 |
October 07, 2023 |
| Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 |
R01
|
December 21, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research- NOT-AI-21-011 |
R21
|
February 12, 2021 |
May 08, 2024 |
| Notice of Special Interest (NOSI)—Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health- NOT-EB-21-001 |
R41/R42, R43/R44
|
February 22, 2021 |
April 06, 2023 |
| Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080 |
R21, R01
|
October 18, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Synthetic Biology for Biomedical Applications- NOT-EB-20-017 |
R01
|
November 24, 2020 |
January 19, 2024 |
| Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 |
R01, R41/R42, R21, R43/R44
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Understanding the Immune Functions of DEAD/H-box Helicases- NOT-AI-21-066 |
R21, R01
|
July 22, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Using the Collaborative Cross (CC) Mouse Model for Immunoregulatory and Infectious Disease Research- NOT-AI-21-071 |
R01, R21
|
July 29, 2021 |
September 08, 2024 |
| Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 |
Supp
|
May 20, 2022 |
July 06, 2022 |
| Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)- PAR-21-343 |
U01
|
November 19, 2021 |
April 19, 2024 |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 |
R01
|
May 10, 2022 |
September 15, 2022 |
